Schedule 13G ownership disclosure

ALX Oncology Holdings, Inc.

Security class unavailable · CUSIP: 00166B105

Event date: 2021-08-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,205,127
Percent of class
10.4200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-21-000387
Form type
SC 13G
Filer
ALX ONCOLOGY HOLDINGS INC
CIK
CIK 1810182
Filed
Sep 10, 2021
Reporting period
Aug 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub